Exact Mass: 306.0787

Exact Mass Matches: 306.0787

Found 7 metabolites which its exact mass value is equals to given mass value 306.0787, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

N4-Acetylsulfamonomethoxine

N-{4-[(6-methylpyrimidin-4-yl)sulfamoyl]phenyl}acetamide

C13H14N4O3S (306.0787)


   

2-(difluoromethyl)-7,8-difluoro-4-phenyl-3H-benzo[b][1,4]diazepine

2-(difluoromethyl)-7,8-difluoro-4-phenyl-3H-benzo[b][1,4]diazepine

C16H10F4N2 (306.078)


   

4-(BENZYLAMINO)-2-(METHYLSULFONYL)PYRIMIDINE-5-CARBOXAMIDE

4-(BENZYLAMINO)-2-(METHYLSULFONYL)PYRIMIDINE-5-CARBOXAMIDE

C13H14N4O3S (306.0787)


   

5-Thiazolecarboxylic acid, 2-amino-4-methyl-, 2-[(4-hydroxy-3-methoxyphenyl)methylene]hydrazide

5-Thiazolecarboxylic acid, 2-amino-4-methyl-, 2-[(4-hydroxy-3-methoxyphenyl)methylene]hydrazide

C13H14N4O3S (306.0787)


   

N2-Formylsulfisomidine

N2-Formylsulfisomidine

C13H14N4O3S (306.0787)


   

5-[2-Furanyl(4-morpholinyl)methyl]-6-thiazolo[3,2-b][1,2,4]triazolol

5-[2-Furanyl(4-morpholinyl)methyl]-6-thiazolo[3,2-b][1,2,4]triazolol

C13H14N4O3S (306.0787)


   

TM6089

TM6089

C13H14N4O3S (306.0787)


TM6089 is a unique Prolyl Hydroxylase (PHD) inhibitor which stimulates HIF activity without iron chelation and induces angiogenesis and exerts organ protection against ischemia. Local administration of TM6089 enhances angiogenesis, and oral administration stimulates HIF activity in transgenic rats expressing a hypoxia-responsive reporter vector[1].